Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Treatment failure: case reportA 47-year-old man exhibited treatment failure with streptokinase for anterior ST-elevation acute myocardial infarction (STEMI). The man, who was a smoker, was admitted to a hospital in Bangladesh from a remote hospital after the failure of streptokinase therapy to reperfuse anterior STEMI. He was previously presented to a local hospital in Bangladesh with a severe retrosternal pain for duration of 6h. As a result, a diagnosis of anterior STEMI was made. Therefore, he received first-line reperfusion therapy with IV streptokinase 1.5 million units concomitantly with morphine. He additionally received aspirin, clopidogrel and atorvastatin. After 2.5h of streptokinase administration, he was admitted to the department of cardiology catheterisation laboratory due to ongoing severe chest pain without any signs of reperfusion. On admission, he had persistent ST-segment elevation in the anterior leads. Additionally, he had left ventricular anterior wall akinesia with normal muscle thickness and hypercontractility of the inferior segments. The coronary angiography revealed a proximal left anterior descending coronary artery occlusion. Thus, treatment failure with streptokinase was considered. Thereafter, he received heparin [unfractionated heparin] for peri-procedural anticoagulation. After vessel wiring, thrombus aspiration was performed. Due to the failure of streptokinase therapy, he underwent an implantation of novel thin-strut bioresorbable-polymer sirolimus-eluting stent. The control angiography then showed lack of residual stenosis and lack of distal embolism. The laboratory findings showed an optimal reconstruction of the lumen in absence of any dissection and in absence of any in-stent thrombotic or plaque material and showed fully preserved side-branch access. After 3 days, he was discharged home in a good clinical condition.Malik F-T-N, et al. Thin-strut bioresorbable-polymer sirolimus-eluting stent use for an optimal result of rescue coronary angioplasty in acute myocardial infarction failed
Treatment failure: case reportA 47-year-old man exhibited treatment failure with streptokinase for anterior ST-elevation acute myocardial infarction (STEMI). The man, who was a smoker, was admitted to a hospital in Bangladesh from a remote hospital after the failure of streptokinase therapy to reperfuse anterior STEMI. He was previously presented to a local hospital in Bangladesh with a severe retrosternal pain for duration of 6h. As a result, a diagnosis of anterior STEMI was made. Therefore, he received first-line reperfusion therapy with IV streptokinase 1.5 million units concomitantly with morphine. He additionally received aspirin, clopidogrel and atorvastatin. After 2.5h of streptokinase administration, he was admitted to the department of cardiology catheterisation laboratory due to ongoing severe chest pain without any signs of reperfusion. On admission, he had persistent ST-segment elevation in the anterior leads. Additionally, he had left ventricular anterior wall akinesia with normal muscle thickness and hypercontractility of the inferior segments. The coronary angiography revealed a proximal left anterior descending coronary artery occlusion. Thus, treatment failure with streptokinase was considered. Thereafter, he received heparin [unfractionated heparin] for peri-procedural anticoagulation. After vessel wiring, thrombus aspiration was performed. Due to the failure of streptokinase therapy, he underwent an implantation of novel thin-strut bioresorbable-polymer sirolimus-eluting stent. The control angiography then showed lack of residual stenosis and lack of distal embolism. The laboratory findings showed an optimal reconstruction of the lumen in absence of any dissection and in absence of any in-stent thrombotic or plaque material and showed fully preserved side-branch access. After 3 days, he was discharged home in a good clinical condition.Malik F-T-N, et al. Thin-strut bioresorbable-polymer sirolimus-eluting stent use for an optimal result of rescue coronary angioplasty in acute myocardial infarction failed
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.